This activity is expired and is no longer available for CME credit.

  • Examining the Psychosocial Ramifications of Type 1 Diabetes in Children
  • CME
  • Examining the Psychosocial Ramifications of Type 1 Diabetes in Children

  • Author(s)/Faculty: Gun Forsander, MD, PhD; Alan Delamater, PhD; David H. Madoff, MD, PhD; Thomas W. Donner, MD; Linda Siminerio, RN, PhD, CDE; Gun Forsander, MD, PhD
    Source: Johns Hopkins University
    Type: Multimedia Articles/Items: 1
    Release Date: 12/31/2011 Expiration Date: 1/23/2013
    Credit Type: Physician / Non-Physician Number of Credit(s): 1.5
    Cost: Free Provider: Johns Hopkins
  • Type 1 diabetes mellitus (T1DM) is a complex disease requiring constant vigilance and special training to ensure healthy outcomes. A collaborative relationship between the child with T1DM and his or her parents is essential for proper monitoring and care. Adolescence represents a critical time in which glycemic control may suffer. It is imperative that parents and guardians maintain a delicate balance with respect to honoring the child’s need for independence yet providing necessary support. Through compelling patient interviews and interactive cases, this activity will educate clinicians on various strategies that will help adolescents with T1DM and their families cope with the disease, improve treatment adherence, and identify/address negative psychosocial issues.

Presented by the Johns Hopkins University School of Medicine. Supported by an educational grant from Lilly USA, LLC

OVERVIEW
Type 1 diabetes mellitus (T1DM) is a complex disease requiring constant vigilance and special training to ensure healthy outcomes. A collaborative relationship between the child with T1DM and his or her parents is essential for proper monitoring and care. Adolescence represents a critical time in which glycemic control may suffer. It is imperative that parents and guardians maintain a delicate balance with respect to honoring the child’s need for independence yet providing necessary support. Through compelling patient interviews and interactive cases, this activity will educate clinicians on various strategies that will help adolescents with T1DM and their families cope with the disease, improve treatment adherence, and identify/address negative psychosocial issues.

TARGET AUDIENCE
This activity is designed for clinicians who treat pediatric and adolescent patients with diabetes. No prerequisites required.

GOAL
The goal is to help clinicians improve understanding and communication with their patients and families living with T1DM, ensuring effective interventions for handling glycemic control and psychosocial issues.

LEARNING OBJECTIVES
After participating in this activity, the participant will demonstrate the ability to:

  • ASSESS psychosocial issues associated with T1DM in children and adolescents.
  • EVALUATE effective interventions for understanding and managing psychosocial issues associated with T1DM in children and adolescents.
  • EXPLAIN effective management strategies to parents, children, and other caretakers when children may be away from the home or in transition to adulthood.
  • INTEGRATE multi-professional team members into their practice when caring for children and adolescents with T1DM.

The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

ACCREDITATION STATEMENT
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

After reviewing this online activity, participants may receive credit by completing the CME test, evaluation, and receiving a score of 75% or higher.

The estimated time to complete this activity: 1.5 hours.

Release date: December 31, 2011. Expiration date: December 31, 2013.

FULL DISCLOSURE POLICY AFFECTING CME ACTIVITIES
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) to require signed disclosure of the existence of financial relationships with industry from any individual in a position to control the content of a CME activity sponsored by OCME. Members of the Planning Committee are required to disclose all relationships regardless of their relevance to the content of the activity. Faculty are required to disclose only those relationships that are relevant to their specific presentation. The following relationships have been reported for this activity:

Faculty

Thomas W. Donner, MD (Co-Chair)
Acting Director, Johns Hopkins Diabetes Center
Associate Professor of Medicine
Division of Endocrinology
Johns Hopkins University School of Medicine
Baltimore, Maryland

David H. Madoff, MD, PhD (Co-Chair)
Assistant Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland

Alan Delamater, PhD
Professor of Pediatrics and Psychology
Department of Pediatrics
University of Miami Miller School of Medicine
Miami, Florida

Gun Forsander, MD, PhD
Pediatric Diabetologist
Head of Pediatric Diabetes Clinic at The Queen Silvia Children’s Hospital
Sahlgrenska University Hospital
Gothenburg, Sweden

Linda Siminerio, RN, PhD, CDE
Director of the University of Pittsburgh Diabetes Institute
Associate Professor at the University of Pittsburgh
School of Medicine and the School of Nursing
Past Vice President of American Diabetes Association
Pittsburgh, Pennsylvania

Participating Faculty Disclosures
Dr Siminerio reports serving on a medical advisory board for Lilly USA, LLC.

No other speakers have indicated that they have any financial interests or relationships with a commercial entity whose products or services are relevant to the content of their presentation(s).

Planners
No planner has indicated that they have any financial interests or relationships with a commercial entity.

Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution that receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).

OFF-LABEL PRODUCT DISCUSSION
No faculty member has indicated that their presentation will include information on off-label products.

DISCLAIMER
The opinions and recommendations expressed by faculty and other experts whose input is included in this activity are their own. This activity is produced for educational purposes only. Use of Johns Hopkins University School of Medicine name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.

INTERNET CME POLICY
The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protect the privacy of its members and customers. Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals, and the public. Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based activity. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine’s CME activity. CME collects only the information necessary to provide you with the services that you request.

CONFIDENTIALITY DISCLAIMER FOR CME ACTIVITY PARTICIPANT
I certify that I am participating in this Johns Hopkins University School of Medicine activity for CME-accredited training and/or educational purposes.

I understand that while I am participating in this capacity, I may be exposed to "protected health information," as that term is defined and used in Johns Hopkins policies and in the federal HIPAA privacy regulations (the "Privacy Regulations"). Protected health information is information about a person’s health or treatment that identifies the person. I also understand that while I am participating in this capacity I will be treated as a temporary member of Johns Hopkins for purposes of the Privacy Regulations only.

I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential.

I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is: Johns Hopkins Privacy Officer, telephone: 410-735-6509, e-mail: HIPAA@jhmi.edu.

“The Office of Continuing Medical Education at the Johns Hopkins University School of Medicine, as sponsor of this activity, has relayed information with the CME attendees/participants and certify that the visitor is here for training, education and/or observation purposes only.”

Johns Hopkins University School of Medicine
Office of Continuing Medical Education
720 Rutland Avenue/ Turner 20
Baltimore, Maryland 21205-2195
Reviewed & Approved by: General Counsel, Johns Hopkins Medicine (4/1/09)

ACTIVITY
Instructions

Please complete the pre-test, listen to the following presentation, and complete the post-test and evaluation to receive CME credit for this activity.

PRE-TEST

ARCHIVE

Conference Goals

Opening Video: Patient and Parent Perspective Comments
Alan Delamater, PhD

T1DM Topic Introduction
David H. Madoff, MD, PhD

Patient Adherence/Compliance
Alan Delamater, PhD

Video Case Study and Discussion: Adherence Issues Demonstrated
Linda Siminerio, RN, PhD, CDE

Interventions
Gun Forsander, MD, PhD

Video Case Study and Discussion: Faculty Panel & Q&A
Linda Siminerio, RN, PhD, CDE

Final Remarks

POST-TEST